BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1614 related articles for article (PubMed ID: 28038892)

  • 1. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
    Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine signature associated with disease severity in chronic fatigue syndrome patients.
    Montoya JG; Holmes TH; Anderson JN; Maecker HT; Rosenberg-Hasson Y; Valencia IJ; Chu L; Younger JW; Tato CM; Davis MM
    Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7150-E7158. PubMed ID: 28760971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M; Twisk FN; Kubera M; Ringel K
    J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep Quality in Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Josev EK; Jackson ML; Bei B; Trinder J; Harvey A; Clarke C; Snodgrass K; Scheinberg A; Knight SJ
    J Clin Sleep Med; 2017 Sep; 13(9):1057-1066. PubMed ID: 28760189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M; Twisk FN; Johnson C
    Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.
    Landi A; Broadhurst D; Vernon SD; Tyrrell DL; Houghton M
    Cytokine; 2016 Feb; 78():27-36. PubMed ID: 26615570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
    Castro-Marrero J; Zaragozá MC; Domingo JC; Martinez-Martinez A; Alegre J; von Schacky C
    Prostaglandins Leukot Essent Fatty Acids; 2018 Dec; 139():20-24. PubMed ID: 30471769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
    Strassheim VJ; Sunnquist M; Jason LA; Newton JL
    BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cytokines and psychiatric symptoms in chronic fatigue syndrome and healthy controls.
    Groven N; Fors EA; Iversen VC; White LR; Reitan SK
    Nord J Psychiatry; 2018 Nov; 72(8):556-560. PubMed ID: 30063870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.
    Domingo JC; Battistini F; Cordobilla B; Zaragozá MC; Sanmartin-Sentañes R; Alegre-Martin J; Cambras T; Castro-Marrero J
    J Transl Med; 2024 Apr; 22(1):343. PubMed ID: 38600563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study.
    Castro-Marrero J; Faro M; Aliste L; Sáez-Francàs N; Calvo N; Martínez-Martínez A; de Sevilla TF; Alegre J
    Psychosomatics; 2017; 58(5):533-543. PubMed ID: 28596045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor self-reported sleep quality and health-related quality of life in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
    Castro-Marrero J; Zaragozá MC; González-Garcia S; Aliste L; Sáez-Francàs N; Romero O; Ferré A; Fernández de Sevilla T; Alegre J
    J Sleep Res; 2018 Dec; 27(6):e12703. PubMed ID: 29770505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
    Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.